The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Selective MT 2 melatonin receptor antagonists block melatonin‐mediated phase advances of circadian rhythms
Abstract
This study demonstrates the involvement of the MT 2 (Mel 1b ) melatonin receptor in mediating phase advances of circadian activity rhythms by melatonin. In situ hybridization histochemistry with digoxigenin‐labeled oligonucleotide probes revealed for the first time the expression of mt 1 and MT 2 melatonin receptor mRNA within the suprachiasmatic nucleus of the C3H/HeN mouse. Melatonin (0.9 to 30 μg/mouse, s.c.) administration during 3 days at the end of the subjective day (CT 10) to C3H/HeN mice kept in constant dark phase advanced circadian rhythms of wheel running activity in a dose‐dependent manner [EC 50 = 0.72 μg/mouse; 0.98 ± 0.08 h ( n = 15) maximal advance at 9 μg/mouse]. Neither the selective MT 2 melatonin receptor antagonists 4P‐ADOT and 4P‐PDOT (90 μ/mouse, s.c.) nor luzindole (300 μg/mouse, s.c.), which shows 25‐fold higher affinity for the MT 2 than the mt 1 subtype, affected the phase of circadian activity rhythms when given alone at CT 10. All three antagonists, however, shifted to the right the dose‐response curve to melatonin, as they significantly reduced the phase shifting effects of 0.9 and 3 mg melatonin. This is the first study to demonstrate that melatonin phase advances circadian rhythms by activation of a membrane‐bound melatonin receptor and strongly suggests that this effect is mediated through the MT 2 melatonin receptor subtype within the circadian timing system. We conclude that the MT 2 melatonin receptor subtype is a novel therapeutic target for the development of subtype‐selective analogs for the treatment of circadian sleep and mood‐related disorders.—Dubocovich, M. L., Yun, K., Al‐Ghoul, W. M., Benloucif, S., Masana, M. I. Selective MT 2 melatonin receptor antagonists block melatonin‐mediated phase advances of circadian rhythms. FASEB J. 12, 1211–1220 (1998)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302
Basic local alignment search tool
Altschul, S. F., Gish, W., Miller, W., Myers, E. W., & Lipman, D. J. (1990) · Journal of Molecular Biology · doi:10.1006/jmbi.1990.9999 · Cited by 98,669
Yung-Chi, C., & Prusoff, W. H. (1973) · Biochemical Pharmacology · doi:10.1016/0006-2952(73)90196-2 · Cited by 12,922
Reppert, S. M., Weaver, D. R., & Ebisawa, T. (1994) · Neuron · doi:10.1016/0896-6273(94)90055-8 · Cited by 1,096 · cited 4×
“The denomination ‘mt1’ corresponds to that of the recombinant melatonin receptor subtype previously known as Mel1a, which does not show well-defined functional characteristics (18).”
BackgroundInfluentialReppert, S. M., Godson, C., Mahle, C. D., Weaver, D. R., Slaugenhaupt, S. A., & Gusella, J. F. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.19.8734 · Cited by 881
Molecular Dissection of Two Distinct Actions of Melatonin on the Suprachiasmatic Circadian Clock
Liu, C., Weaver, D. R., Jin, X., Shearman, L. P., Pieschl, R. L., Gribkoff, V. K., & Reppert, S. M. (1997) · Neuron · doi:10.1016/s0896-6273(00)80350-5 · Cited by 723
Melatonin Shifts Human Orcadian Rhythms According to a Phase-Response Curve
Lewy, A. J., Ahmed, S., Jackson, J. M. L., & Sack, R. L. (1992) · Chronobiology International · doi:10.3109/07420529209064550 · Cited by 693
Melatonin receptors: Localization, molecular pharmacology and physiological significance
Morgan, P. J., Barrett, P., Howell, H. E., & Helliwell, R. (1994) · Neurochemistry International · doi:10.1016/0197-0186(94)90100-7 · Cited by 623
Melatonin is a potent modulator of dopamine release in the retina
Dubocovich, M. L. (1983) · Nature · doi:10.1038/306782a0 · Cited by 510
Self-citationEffects of melatonin on vertebrate circadian systems
Cassone, V. M. (1990) · Trends in Neurosciences · doi:10.1016/0166-2236(90)90099-v · Cited by 413
Circadian rhythm abnormalities in totally blind people: incidence and clinical significance
Sack, R. L. (1992) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.75.1.127 · Cited by 408
Melatonin receptors: Are there multiple subtypes?
Dubocovich, M. L. (1995) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)88978-6 · Cited by 403
Self-citationMelatonin: Biosynthesis, Physiological Effects, and Clinical Applications
Yu, H.-S., & Reiter, R. J. (1992) · Cited by 397
Dubocovich, M. L., Masana, M. I., Iacob, S., & Sauri, D. M. (1997) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/pl00004956 · Cited by 331
Self-citationMelatonin Content of the Pineal Gland in Different Mouse Strains
Goto, M., Oshima, I., Tomita, T., & Ebihara, S. (1989) · Journal of Pineal Research · doi:10.1111/j.1600-079x.1989.tb00667.x · Cited by 282
Sleep-inducing effects of low doses of melatonin ingested in the evening*
Zhdanova, I. V., Wurtman, R. J., Lynch, H. J., Ives, J. R., Dollins, A. B., Morabito, C., Matheson, J. K., & Schomer, D. L. (1995) · Clinical Pharmacology & Therapeutics · doi:10.1016/0009-9236(95)90040-3 · Cited by 282
McArthur, A. J., Hunt, A. E., & Gillette, M. U. (1997) · Endocrinology · doi:10.1210/en.138.2.627 · Cited by 262
Melatonin mediates two distinct responses in vascular smooth muscle
Doolen, S., Krause, D. N., Dubocovich, M. L., & Duckles, S. P. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00064-8 · Cited by 229 · cited 2×
“mt1 Inhibition of neuronal firing C57/BJ mouse SCN mt1 knockout (11) Vasoconstriction Rat caudal artery Nonselective antagonists (34, 40) MT2 Inhibition of dopamine release Rabbit retina Selective antagonists (9) Phase shift of circadian activity rhythms C3H/HeN Mouse MT2 selective antagonist Present results Vasodilat…”
BackgroundSelf-citationLuzindole (N-0774): a novel melatonin receptor antagonist.
Dubocovich, M. L. (1988) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22188-7 · Cited by 210
Self-citationLyncaro, A. (1969) · Torquere · doi:10.25071/1488-5182.36616 · Cited by 206
Rhythmic transcription: the molecular basis of circadian melatonin synthesis
Foulkes, N. S., assone-Corsi, P., Borjigin, J., Snyder, S. H., & Snyder, S. H. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(97)01109-0 · Cited by 174
Melatonin analogues as agonists and antagonists in the circadian system and other brain areas
Ying, S.-W., Rusak, B., Delagrange, P., Mocaër, E., Renard, P., & Guardiola-Lemaître, B. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00684-2 · Cited by 114 · cited 2×
“The best characterized responses to melatonin in mammals are inhibition of dopamine release from retina (4, 9), modulation of neuronal firing ( 10 , 11), and phase shifts of circadian rhythms (12, 13) through an action within the suprachiasmatic nucleus (SCN)2 of the hypothalamus, site”
BackgroundMelatonin and Light Induce Phase Shifts of Circadian Activity Rhythms in the C3H/HeN Mouse
Benloucif, S., & Dubocovich, M. L. (1996) · Journal of Biological Rhythms · doi:10.1177/074873049601100204 · Cited by 113
Self-citationKrause, D. N., Barrios, V. E., & DUCKLES, S. P. (1995) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00028-j · Cited by 111
Miranda, R. C., & Toran‐Allerand, C. D. (1992) · Cerebral Cortex · doi:10.1093/cercor/2.1.1 · Cited by 106
Laitinen, J. T., & Saavedra, J. M. (1990) · Endocrinology · doi:10.1210/endo-126-4-2110 · Cited by 102
Witt‐Enderby, P. A., & Dubocovich, M. L. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09133-3 · Cited by 99
Self-citationMelatonin inhibits metabolic activity in the rat suprachiasmatic nuclei
Cassone, V. M., Roberts, M. H., & Moore, R. Y. (1987) · Neuroscience Letters · doi:10.1016/0304-3940(87)90335-1 · Cited by 99
Melatonin receptors in the mammalian suprachiasmatic nucleus
Dubocovich, M. L., Benloucif, S., & Masana, M. I. (1995) · Behavioural Brain Research · doi:10.1016/0166-4328(96)00086-1 · Cited by 87
Self-citationMiller, J. A., & Zahniser, N. R. (1987) · Neuroscience Letters · doi:10.1016/0304-3940(87)90408-3 · Cited by 85
X. International Union of Pharmacology recommendations for nomenclature of new receptor subtypes.
Vanhoutte, P. M., Humphrey, P. P. A., & Spedding, M. (1996) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06936-4 · Cited by 78
Siuciak, J. A., Fang, J., & Dubocovich, M. L. (1990) · European Journal of Pharmacology · doi:10.1016/0014-2999(90)90328-4 · Cited by 66
Self-citationResponsiveness to melatonin and its receptor expression in the aging circadian clock of mice
Benloucif, S., Masana, M. I., & Dubocovich, M. L. (1997) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1997.273.6.r1855 · Cited by 49
Self-citationHagan, R. M., & Oakley, N. R. (1995) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)88985-3 · Cited by 44
Conway, S., Drew, J. E., Canning, S. J., Barrett, P., Jockers, R., Strosberg, A. D., Lemaître, B. J., Delagrange, P., & Morgan, P. J. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00315-3 · Cited by 37
Cited by
Functional MT1 and MT2 Melatonin Receptors in Mammals
Dubocovich, M. L., & Markowska, M. (2005) · Endocrine · doi:10.1385/endo:27:2:101 · Cited by 812
Self-citationMelatonin membrane receptors in peripheral tissues: Distribution and functions
Slominski, R. M., Reiter, R. J., Schlabritz-Loutsevitch, N., Ostrom, R. S., & Slominski, A. T. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.01.004 · Cited by 675
REVIEW: Gastrointestinal Melatonin: Localization, Function, and Clinical Relevance
Bubenik, G. A. (2002) · Digestive Diseases and Sciences · doi:10.1023/a:1020107915919 · Cited by 655
MT1 and MT2 Melatonin Receptors: A Therapeutic Perspective
Liu, J., Clough, S. J., Hutchinson, A. J., Adamah-Biassi, E. B., Popovska-Gorevski, M., & Dubocovich, M. L. (2016) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010814-124742 · Cited by 630
Self-citationDubocovich, M. L., Delagrange, P., Krause, D. N., Sugden, D., Cardinali, D. P., & Olcese, J. (2010) · Pharmacological Reviews · doi:10.1124/pr.110.002832 · Cited by 621
Self-citation
Metadata
- Authors
- Dubocovich, M. L., Yun, K., Al‐Ghoul, W. M., Benloucif, S., & Masana, M. I.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 1998-09
- Volume
- 12
- Issue
- 12
- Pages
- 1211-1220
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W1852348769
- Cited by
- 364
- References
- 35
- FWCI
- 4.01
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.